Cellestetix logo — CX is Ready for Retail

Cellestetix

CX is Ready for Retail

Founded 2020 Seed Total: $4.67M Biotechnology, Health and Wellness +1

General Information

Company Name Cellestetix
Founded Year 2020
Industries Biotechnology, Health and Wellness, Wellness Beauty
Funding Stage Seed
Social

Get notified when Cellestetix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellestetix

Cellestetix, with its slogan "CX is Ready for Retail," is a promising startup in the Biotechnology sector, leveraging breakthroughs in plant-based exosome technology for regenerative beauty and wellness applications. Based in Turkey, this innovative company was founded in 2020 by genetic engineers Dr. Polen Koçak and Dr. Merve Yıldırım, who bring a decade of combined expertise in biotechnology, genetics, and bioengineering to their venture.

Initially focused on R&D for cancer and wound care, Cellestetix strategically pivoted to address the lucrative cosmetic market. This shift has allowed the company to harness the growing demand for beauty and wellness solutions, positioning them strongly within the Wellness Beauty and Health and Wellness industries.

In its recent funding activities, Cellestetix secured a $1.67 million seed investment on 01 February 2025, illustrating investor confidence in its growth potential. This injection of capital is expected to bolster its commercialization efforts and strategic expansion in the fast-evolving biotechnology landscape.

Taxonomy: plant-based exosomes, regenerative beauty, wellness applications, genetic engineering, bioengineering, cosmetic technology, skin regeneration, hair regeneration, R&D platform, cancer care innovation, wound care innovation

Services & Products

Development of plant-based exosome technologies
Customizable cosmetic and wellness solutions
Market-ready applications for skin and hair care

Target Customers

Retailers in beauty and wellness industry Consumers seeking innovative skincare solutions Businesses looking for climate-positive, cruelty-free products

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• - 01 Feb 2025
Seed •••••• 5
Investor Investor Investor
•••• ••••
01 Aug 2024
Seed •••••• 1 •••• •••• 01 Mar 2023

Cellestetix Alternatives & Competitors

View All Alternatives
Cellestetix vs

An emerging biotechnology company pioneering breakthrough antibody technology for research, diagnost...

Grant
51-200 employees
Biopharma, Biotechnology
Cellestetix vs
Ai2 Ltd
Ai2 Ltd United Kingdom

Ai2 Ltd is a UK-based biotechnology company that specialises in novel anti-infective peptide technol...

Series Unknown
3 employees
Biopharma, Biotechnology
Cellestetix vs
SelenBio
SelenBio United States

SelenBio brings antimicrobial SELDOX® technology to products and applications where bacteria and bio...

5 employees

FAQ About Cellestetix

CX is Ready for Retail
Cellestetix was founded in 2020.
Cellestetix operates in the following industries: Biotechnology, Health and Wellness, Wellness Beauty.
Cellestetix has completed 3 funding rounds, raising a total of $4.67M. The latest funding stage is Seed.
Cellestetix offers: Development of plant-based exosome technologies, Customizable cosmetic and wellness solutions, Market-ready applications for skin and hair care.
Top alternatives and competitors to Cellestetix include Somru Bioscience, Ai2 Ltd, SelenBio, Kerecis, SparkBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellestetix and Somru Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellestetix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy